PegIntron

In the US, PegIntron (peginterferon alfa-2b systemic) is a member of the following drug classes: antineoplastic interferons, antiviral interferons and is used to treat Chronic Myelogenous Leukemia, Hepatitis B, Hepatitis C, Melanoma, Melanoma - Metastatic, Renal Cell Carcinoma and Thrombocythemia.

US matches:

Ingredient matches for PegIntron

Peginterferon Alfa 2-b

Peginterferon Alfa 2-b is reported as an ingredient of PegIntron in the following countries:

  • Austria
  • Belgium
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Finland
  • Georgia
  • Germany
  • Greece
  • Hungary
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Peru
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United States
  • Venezuela
  • Vietnam

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)